title: Suprahyoid Hodgkin's disease stage IA.
abstract: From 1973 to 1987, 71 patients (age greater than or equal to 16 years) with stage IA supradiaphragmatic Hodgkin's disease were treated with radiotherapy alone. 23 patients (20, clinical stage; 3, pathological stage) had disease localised to the suprahyoid region of the neck (upper deep cervical, 11; submandibular, 6; submandibular and upper deep cervical, 5; submental, 1). The age range was 17 to 64 (median 33). The male to female ratio was 2.8:1. The histological types were: lymphocyte predominant, 11; nodular sclerosis grade I, 8; mixed cellularity, 4. The 5 and 10 year cause-specific survival was 100% with a disease-free survival of 90% at 5 and 10 years. The proportion of patients with suprahyoid Hodgkin's disease IA was constant over the 15-year period. This only became apparent when the histology of patients with suprahyoid non-Hodgkin's lymphoma stage IA was reviewed.
authors.affiliation: Department of Clinical Oncology, General Hospital, Nottingham, U.K.
authors.forename: E M
authors.initials: EM
authors.lastname: Bessell
authors.forename: K A
authors.initials: KA
authors.lastname: MacLennan
authors.forename: P J
authors.initials: PJ
authors.lastname: Toghill
authors.forename: I O
authors.initials: IO
authors.lastname: Ellis
authors.forename: J
authors.initials: J
authors.lastname: Fletcher
authors.forename: F D
authors.initials: FD
authors.lastname: Dowling
mesh_terms: D000293:Adolescent; D000328:Adult; D004307:Dose-Response Relationship, Radiation; D005260:Female; D006258:Head and Neck Neoplasms / Q000473:pathology / Q000532:radiotherapy; D006689:Hodgkin Disease / Q000473:pathology / Q000532:radiotherapy*; D006801:Humans; D007573:Jaw Neoplasms / Q000473:pathology / Q000532:radiotherapy; D015182:Lymphatic Irradiation; D008228:Lymphoma, Non-Hodgkin / Q000473:pathology / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011879:Radiotherapy Dosage; D015996:Survival Rate